We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 10,000 results
  1. Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116)

    Purpose

    In patients with metastatic pancreatic cancer, after failure of gemcitabine/nab-paclitaxel, this trial compares the efficacy of second-line...

    Dominik Paul Modest, Volker Heinemann, ... Helmut Oettle in Journal of Cancer Research and Clinical Oncology
    Article Open access 01 July 2024
  2. Recurrence in isolated distal DVT after anticoagulation: a systematic review and meta-analysis of axial and muscular venous thrombosis

    Objective

    To identify recurrent venous thromboembolism (VTE) after discontinuation of anticoagulation in patients with isolated distal deep vein...

    Wen-Tao Yang, Zhen-Yi **, ... Hua-Liang Ren in Thrombosis Journal
    Article Open access 01 July 2024
  3. Metabolomic profiling of upper GI malignancies in blood and tissue: a systematic review and meta-analysis

    Objective

    To conduct a systematic review and meta-analysis of case–control and cohort human studies evaluating metabolite markers identified using...

    Ilja Balonov, Minca Mattis, ... Sven Jacob in Journal of Cancer Research and Clinical Oncology
    Article Open access 01 July 2024
  4. Complement C3a/C3aR and C5a/C5aR deposits accelerate the progression of advanced IgA nephropathy to end-stage renal disease

    IgA nephropathy (IgAN) is still one of the leading causes of end-stage kidney disease (ESRD), and complement system activation is a key to the...

    Ying Wang, Shunlai Shang, ... Wenge Li in Clinical and Experimental Medicine
    Article Open access 29 June 2024
  5. The potential role of serum amyloid A as biomarker of rheumatic diseases: a systematic review and meta-analysis

    The identification of novel, robust biomarkers for the diagnosis of rheumatic diseases (RDs) and the presence of active disease might facilitate...

    Angelo Zinellu, Arduino A. Mangoni in Clinical and Experimental Medicine
    Article Open access 29 June 2024
  6. ISG15 promotes tumor progression via IL6/JAK2/STAT3 signaling pathway in ccRCC

    Although renal cell carcinoma (RCC) is a prevalent type of cancer, the most common pathological subtype, clear cell renal cell carcinoma (ccRCC),...

    Wei **e, Yuanfeng Zhang, ... Ronggui Zhang in Clinical and Experimental Medicine
    Article Open access 29 June 2024
  7. Cancer fatalism, social media informational awareness, and education

    Objective

    Understand if cancer fatalism among adult social media users in the United States is linked to social media informational awareness and if...

    Jim P. Stimpson, Sungchul Park, ... Alexander N. Ortega in Cancer Causes & Control
    Article 29 June 2024
  8. Daily Versus Alternate Day Oral Iron Replacement for Women with Iron Deficiency Anaemia: A Randomized Controlled Trial

    The optimal way of oral iron replacement for iron deficiency anaemia(IDA) is still unknown and few recent studies have reported better fractional...

    Mallesh Dhanush, Kolar Vishwanath Vinod, ... Dhanajayan Govindan in Indian Journal of Hematology and Blood Transfusion
    Article 29 June 2024
  9. PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinoma

    Both atezolizumab (a PD-L1 inhibitor) plus bevacizumab (A+B) and sintilimab (a PD-1 inhibitor) plus bevacizumab (S+B) are recommended as the...

    Zhenkun Huang, Tiejun Chen, ... Wei He in Clinical and Experimental Medicine
    Article Open access 28 June 2024
  10. The landscape of RNA-chromatin interaction reveals small non-coding RNAs as essential mediators of leukemia maintenance

    RNA constitutes a large fraction of chromatin. Spatial distribution and functional relevance of most of RNA-chromatin interactions remain unknown. We...

    Haiyang Yun, Julian Zoller, ... Carsten Müller-Tidow in Leukemia
    Article Open access 28 June 2024
  11. Update on kidney injury caused by multiple myeloma

    Multiple myeloma (MM) is a form of clonal plasma cell malignancy that associates with clinical manifestations such as anemia, hypercalcemia, bone...

    Linhui Wang, Chen Liu, ... Yiyao Deng in Annals of Hematology
    Article 28 June 2024
  12. Cancer metastasis through the lymphatic versus blood vessels

    Whether cancer cells metastasize from the primary site to the distant sites via the lymphatic vessels or the blood vessels directly into the...

    Stanley P. Leong, Marlys H. Witte in Clinical & Experimental Metastasis
    Article Open access 28 June 2024
  13. Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis

    Background

    In recent years, extracorporeal membrane oxygenation (ECMO) has been increasingly used in critically ill patients with respiratory or...

    Danyu Song, Yu **, ... Zhou Zhou in Thrombosis Journal
    Article Open access 28 June 2024
  14. Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome

    Background

    Hypercoagulability emerges as a central pathological feature and clinical complication in nephrotic syndrome. Increased platelet activation...

    Shi-** Na, Mei-Liang Ning, ... Yu-Shi Bao in Thrombosis Journal
    Article Open access 28 June 2024
  15. Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches

    In recent decades, the field of systemic cancer treatment has seen remarkable changes due to advancements in the understanding of cancer’s biology,...

    Article 27 June 2024
  16. Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib

    Acquired pure red cell aplasia (PRCA) is a rare syndrome characterized by normocytic normochromic anemia with severe reticulocytopenia and absence of...

    Yuemin Gong, Yue Li, ... Lei Fan in Annals of Hematology
    Article 27 June 2024
  17. Risk factors and long-term outcomes for human herpesvirus 6 encephalitis in the early period after allogeneic stem cell transplantation

    Human herpesvirus 6 (HHV6) encephalitis is a rare but life-threatening complication for patients undergoing allogeneic hematopoietic stem cell...

    Yi Yu, Weihao Chen, ... Yanmin Zhao in Bone Marrow Transplantation
    Article 27 June 2024
Did you find what you were looking for? Share feedback.